Cargando…

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation

OBJECTIVES: To assess the risk of stroke/systemic embolism (SE) and major bleeding associated with the use of oral anticoagulants in elderly patients with atrial fibrillation (AF) in a real-world population. METHODS: We identified all anticoagulant-naive initiators of warfarin, dabigatran, rivaroxab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rutherford, Ole-Christian Walter, Jonasson, Christian, Ghanima, Waleed, Söderdahl, Fabian, Halvorsen, Sigrun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862105/ https://www.ncbi.nlm.nih.gov/pubmed/33975877 http://dx.doi.org/10.1136/heartjnl-2020-318753

Ejemplares similares

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry
por: Guidoux, Celine, et al.
Publicado: (2019)

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation
por: Melduni, Rowlens M, et al.
Publicado: (2020)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease
por: Batra, Gorav, et al.
Publicado: (2022)

Anticoagulation trends in adults aged 65 years and over with atrial fibrillation: a cohort study
por: Lund, Jenny, et al.
Publicado: (2021)

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
por: Sandhu, Roopinder K, et al.
Publicado: (2018)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation
por: Jackson, Adam, et al.
Publicado: (2021)

Comparative effectiveness of oral anticoagulants in everyday practice
por: Camm, A John, et al.
Publicado: (2021)

Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatran
por: Choi, Eue-Keun, et al.
Publicado: (2020)

Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation
por: Parwani, Abdul Shokor, et al.
Publicado: (2017)

Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care
por: Lyckhage, Louise Feldborg, et al.
Publicado: (2021)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Inflammatory proteomics profiling for prediction of incident atrial fibrillation
por: Börschel, Christin S, et al.
Publicado: (2023)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Association of income and health-related quality of life in atrial fibrillation
por: Guhl, Emily, et al.
Publicado: (2019)

Catheter ablation for the management of atrial fibrillation: current technical perspectives
por: Hong, Kathryn Lauren, et al.
Publicado: (2020)

Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
por: Moschovitis, Giorgio, et al.
Publicado: (2021)

Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014
por: Kjerpeseth, Lars Jøran, et al.
Publicado: (2021)

Impact of COVID-19 on patients awaiting ablation for atrial fibrillation
por: Pius, Charlene, et al.
Publicado: (2022)

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland
por: Lehto, Mika, et al.
Publicado: (2022)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Quality of life and healthcare utilisation improvements after atrial fibrillation ablation
por: Gupta, Dhiraj, et al.
Publicado: (2021)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Characterising symptom clusters in patients with atrial fibrillation undergoing catheter ablation
por: Hobensack, Mollie, et al.
Publicado: (2023)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Development and validation of prediction models for incident atrial fibrillation in heart failure
por: Vinter, Nicklas, et al.
Publicado: (2023)

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Proposed A(2)C(2)S(2)-VASc score for predicting atrial fibrillation development in patients with atrial flutter
por: Chen, Yung-Lung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bhmpf6ogpkpn8hmtf38g54r7mf